As Dixie Brands celebrates its one-year anniversary of its expansion from its home market of Colorado to California, CEO Tripp Keber shared an update in an interview with Cannabis Now Magazine. Dixie is now in over 400 California dispensaries through its manufacturing partner, Indus Holdings. Keber describes the operating environment there as extremely challenging due to the lack of compliance requirements at the state level and the varying local rules.
No offense to the manufacturer in California, but there were little to no rules to go by until recently. That allows anybody with a spoon, a cellophane baggie, and a dot matrix printer to have an infused products company.
Tripp Keber, Dixie Brands CEO
Dixie plans to use its education in California to pave the way as it enters Arizona, Nevada, Oregon and Washington. One interesting observation is that the Colorado hemp market has developed so much that Keber expect to be able to source the company’s CBD for its Aceso (health and wellness for humans) and Therabis (for pets) lines domestically.
Finally, Keber pointed to the company failing to keep pace with the needs of its core consumer, the medical patient, as it has been focused on the burgeoning adult-use market. Dixie will be bringing on several new “heavy THC” products targeting medical patients in Colorado and California shortly, including the 200mg elixir pictured above.
Read Jimi Devine’s “Boosting THC at Dixie: Tripp Keber Aims to Recapture Cannabis’ Core”: https://cannabisnowmagazine.com/current-events/boosting-thc-at-dixie-tripp-keber-aims-to-recapture-cannabis-core
Are you a cannabis industry thought leader and want to be heard? Let us know your story.
